Parkinson's Disease (PD)
29
9
10
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 29 trials
100.0%
+13.5% vs benchmark
3%
1 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (29)
Attention and Eye Movement in Parkinson's Disease
Mental Health Support for People Affected by Parkinson's
CuePD: Investigating the Effect of Personalised Auditory Cueing on Gait in Parkinson's Disease
Low-Fidelity Driving Simulator Training in Parkinson's Disease.
[18F] - FD17 PET Imaging of α-synuclein: A Clinical Study in α-synucleinopathy Patients
Developing Immersive Gamification Technology Systems For The Rehabilitation Management Of Adults With Parkinson's Disease (Phase 1 Trial)
Accelerated TMS for Freezing of Gait in Parkinson's Disease
Prevention-in-PD-Study
PET-MRI of Reward System in Parkinson's Disease With RBD
Clozapine-related Immunodeficiency in Parkinsons Disease
rTMS Treatment of Dysphagia in Parkinson's Patients
The Effects of Dual Task Training With Different Task Priorities on Physical Performance and Cognitive Status in Patients With Parkinson's Disease
Effects of Transcranial Ultrasound Stimulation (TUS) on Neurological and Cognitive Outcomes in Neurodegenerative Diseases
Closed-Loop Therapeutic Refinement Using Local Field Potentials in Parkinson's Disease
Novel Shoe Device NUSHU to Measure Gait Analysis in Parkinson's Patients
The Effects of Scapulohumeral Rehabilitation on Scapula Kinematics and Upper Extremity Functionality in Individuals With Parkinson's Disease
Safety, Tolerability and Exploratory Efficacy of EC5026 in Parkinson's Disease (STEP Study)
Testing of an Interface for Synchronizing tACS-DBS With a Phase-locked-loop
Parkinson's Research In Metagenomic Early Stage Biomarkers
Randomized, Placebo-Controlled Trial of N-acetylcysteine In Parkinson's Disease Patients: A Pilot Study